This HTML5 document contains 142 embedded RDF statements represented using HTML+Microdata notation.

The embedded RDF content will be recognized by any processor of HTML5 Microdata.

Namespace Prefixes

PrefixIRI
wdthttp://www.wikidata.org/prop/direct/
wdtnhttp://www.wikidata.org/prop/direct-normalized/
schemahttp://schema.org/
skoshttp://www.w3.org/2004/02/skos/core#
rdfshttp://www.w3.org/2000/01/rdf-schema#
n11http://dx.doi.org/10.1007/
wikibasehttp://wikiba.se/ontology#
phttp://www.wikidata.org/prop/
rdfhttp://www.w3.org/1999/02/22-rdf-syntax-ns#
n13http://rdf.ncbi.nlm.nih.gov/pubchem/reference/
xsdhhttp://www.w3.org/2001/XMLSchema#
wdshttp://www.wikidata.org/entity/statement/
n12https://scigraph.springernature.com/pub.10.1007/
wdhttp://www.wikidata.org/entity/

Statements

Subject Item
wd:Q50091898
rdf:type
wikibase:Item
schema:description
vedecký článok научни чланак vědecký článek vitenskapelig artikkel scienca artikolo 2017年學術文章 2017年学术文章 2017年学术文章 2017年学术文章 artigo científico artikel ilmiah articol științific scientific article published on 10 October 2017 2017年の論文 vetenskaplig artikel vitskapeleg artikkel наукова стаття, опублікована в жовтні 2017 artigo científico научна статия scientific article published on 10 October 2017 2017年學術文章 2017年学术文章 wetenschappelijk artikel artikull shkencor სამეცნიერო სტატია 2017年學術文章 επιστημονικό άρθρο wissenschaftlicher Artikel tudományos cikk artigo científico 2017年学术文章 naučni članak artykuł naukowy ১০ অক্টোবর ২০১৭-এ প্রকাশিত বৈজ্ঞানিক নিবন্ধ article científic tieteellinen artikkeli bài báo khoa học article scientifique bilimsel makale scientific article published on 10 October 2017 научная статья مقالة علمية نشرت في 10 أكتوبر 2017 articolo scientifico artículo científico publicado en 2017 article scientific teaduslik artikkel научни чланак מאמר מדעי บทความทางวิทยาศาสตร์ artikulong pang-agham мақолаи илмӣ 2017 nî lūn-bûn 2017年學術文章 2017년 논문 2017年學術文章 artículu científicu videnskabelig artikel 2017 թվականի հոկտեմբերի 10-ին հրատարակված գիտական հոդված 2017年学术文章
p:P577
wds:Q50091898-F5C0757B-2332-43E0-9EB7-57C8121F2D5E
wdt:P577
2017-10-10T00:00:00Z
p:P2888
wds:Q50091898-E4B235E2-D69F-4005-BFA1-352FE6CC06CF
wdt:P2888
n12:s12020-017-1428-9
p:P2860
wds:Q50091898-620307CE-0D3C-43CE-9BE8-F100DAA4A6ED wds:Q50091898-6AFE8BF1-9687-4BDE-A46B-5A4F0C2C4F6B wds:Q50091898-6B36C643-D8D6-434C-937D-126818EA3C26 wds:Q50091898-16846487-6245-4A65-AC21-F318699CE550 wds:Q50091898-1BD1A2FE-055C-4F55-A700-31048E4AEF40 wds:Q50091898-2C6FCB2D-C029-4F4B-A442-3D086E51AFA2 wds:Q50091898-3341B755-B4E9-44B5-98B5-56DE4C48ABE8 wds:Q50091898-37143D6A-6C07-445D-943C-B83AB79ED52D wds:Q50091898-B12C4291-197C-4374-A0BE-4B7EC963E0B3 wds:Q50091898-C88299F7-CC0B-4CB8-8263-94A7093E024C wds:Q50091898-D886F761-C681-4E2E-AC48-E9766683183F wds:Q50091898-827DCD3A-F285-418A-BC73-EFE998FAB117 wds:Q50091898-87F66352-8B77-46CF-943F-9EBF8E7469CD wds:Q50091898-9E3CA407-1244-462A-AAE8-513DBBE2DF4C wds:Q50091898-E54692A0-5C15-47A2-B510-E313F4CCDC7A wds:Q50091898-F3BAEE0D-0D04-46D8-A943-6C425AFE0CF1
wdt:P2860
wd:Q37924869 wd:Q85009898 wd:Q83797708 wd:Q73892786 wd:Q28251224 wd:Q33569920 wd:Q42997941 wd:Q50932867 wd:Q46711346 wd:Q38181425 wd:Q37369828 wd:Q35230486 wd:Q48447621 wd:Q54547133 wd:Q68687393 wd:Q68260118
p:P2093
wds:Q50091898-6E57FA97-C485-4E6C-ADD4-8D23483A1170 wds:Q50091898-4DC0129C-DE05-40D8-84BE-37893969AA35 wds:Q50091898-55ECDFC1-C84F-4341-84CF-1C65A82230F8 wds:Q50091898-41C4B075-843C-4305-9DBB-753803557DD2 wds:Q50091898-4B7AC3AE-1AB1-4C4C-9880-E908ADA20FAF wds:Q50091898-B170F6A7-580C-44B0-82C0-B2E9758A0005 wds:Q50091898-BDEB58E1-ACD4-440E-B3A3-840860C2CB99 wds:Q50091898-A759438A-2FF6-4288-8FE2-3E53E98C4139
wdt:P2093
Paola Perotti Salvatore Grisanti Massimo Terzolo Alfredo Berruti Sara Cerri Sandra Sigala Barbara Lazzari Vittorio Ferrari
rdfs:label
Adding metyrapone to chemotherapy plus mitotane for Cushing's syndrome due to advanced adrenocortical carcinoma. Adding metyrapone to chemotherapy plus mitotane for Cushing's syndrome due to advanced adrenocortical carcinoma.
skos:prefLabel
Adding metyrapone to chemotherapy plus mitotane for Cushing's syndrome due to advanced adrenocortical carcinoma. Adding metyrapone to chemotherapy plus mitotane for Cushing's syndrome due to advanced adrenocortical carcinoma.
schema:name
Adding metyrapone to chemotherapy plus mitotane for Cushing's syndrome due to advanced adrenocortical carcinoma. Adding metyrapone to chemotherapy plus mitotane for Cushing's syndrome due to advanced adrenocortical carcinoma.
p:P50
wds:Q50091898-5C63A5E9-0EC1-41C6-9F2D-B2F107AF17C4 wds:Q50091898-129C8653-E16D-4D0C-A473-85A9663F4D5E
wdt:P50
wd:Q87624014 wd:Q41499544
p:P1476
wds:Q50091898-628017C9-5E19-4F99-872D-D881CB7B5DBF
wdt:P1476
Adding metyrapone to chemotherapy plus mitotane for Cushing's syndrome due to advanced adrenocortical carcinoma
p:P304
wds:Q50091898-D44BE4FD-6D8A-4A98-B2A0-F21A8D017DE1
wdt:P304
169-172
p:P31
wds:Q50091898-17F02934-9592-4340-9588-99AE3F9CF753
wdt:P31
wd:Q13442814
p:P921
wds:Q50091898-841D62A8-37E7-4464-82F3-90A607B61F67
wdt:P921
wd:Q219102
p:P698
wds:Q50091898-A841F995-6328-45FB-AA02-0905711D8203
wdtn:P698
n13:29019062
wdt:P698
29019062
p:P1433
wds:Q50091898-08F6921C-E1E7-48BD-92AA-B9CA1B59EBD1
wdt:P1433
wd:Q15757048
p:P433
wds:Q50091898-9E85CAE3-DED7-4489-89B4-9FA67FFE2418
p:P478
wds:Q50091898-921D20BC-6FCB-4585-B7D6-50E8B22B6EF8
wdt:P433
1
wdt:P478
61
p:P356
wds:Q50091898-AF798AD3-3F2F-49C2-AA14-FD656E565F87
wdtn:P356
n11:S12020-017-1428-9
wdt:P356
10.1007/S12020-017-1428-9